SCHEMBL25890603

SCHEMBL25890603

Cn1ccc(B(O)OC(C)(C)C(C)(C)C)n1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1485660 0.89 KMT2A (0.33) KMT2A
SCHEMBL350714 0.72
SCHEMBL304987 0.61 CYP3A4 (0.33)
Boric Acid SCHEMBL17848604 0.60 NOS1 (0.42) KMT2A
SCHEMBL29776685 0.60
SCHEMBL14994712 0.58 L3MBTL1 (0.33) KMT2A
SCHEMBL11895145 0.58
SCHEMBL2125736 0.58
SCHEMBL18355383 0.57 EPHX2 (0.38) KMT2A
SCHEMBL440932 0.57 KMT2A (0.41) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023128708-A1 PYRAZOLOPYRIMIDINE DERIVATIVE AND ANTICANCER PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT 한국화학연구원 2023-07-06 WO disclosed